Back

GPER stimulation attenuates mitochondrial dysfunction and cardiac dysfunction pathway in ovariectomized mice with HFpEF

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: New prospects on pharmacology and exercise in HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Jing Yu

Lanzhou University Second Hospital, Lanzhou (China)

5 More presentations in this session

Presentation thumbnail
Exhaled breath acetone during rest and exercise reflects haemodynamic stress and reduced functional capacity across the heart-failure spectrum
Professor T. Lomonaco (Pisa, IT)
Abstract
Presentation thumbnail
Anaerobic threshold diastolic function as a novel prognostic marker in older HFpEF patients without requiring peak stress
Doctor J. Morimoto (Wakayama, JP)
Abstract
Presentation thumbnail
Baseline characteristics of a contemporary trial of home-based cardiac rehabilitation in patients with heart failure and preserved ejection fraction – the REACH-HFpEF trial
Professor C. Lang (Dundee, GB)
Abstract
Presentation thumbnail
Prognostic value of blood pressure and heart rate responses during cardiopulmonary exercise testing in patients with heart failure: a stratified analysis by ejection fraction
Ms H. Mibe (JP)
Abstract
Presentation thumbnail
Prognosis and treatment response in cardiometabolic HFpEF: deep learning-based phenomapping with a pragmatic clinical classifier
Professor X. Hua (Beijing, CN)
Abstract

Access the full session

Session thumbnail
New prospects on pharmacology and exercise in HFpEF

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Sex- and age-dependent differences in heart failure development: insights from proteomic, transcriptomic, and functional analyses in double transgenic cyclin T1/Gq alpha subunit mice
1 September 2025
thumbnail
Congress Presentation
The new mechanism of apatinib in treating gastric cancer-related hypertension: dynamin-related protein 1-mediated pathological mitochondrial fission in endothelial cells
1 September 2025
thumbnail
Webinar
GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?
15 December 2025
thumbnail
Congress Presentation
Mitochondrial dysfunction as a contributor to decreased perfusion in heart failure with preserved ejection franction(HFpEF) in a swine model of kidney disease and diabetes
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources